×

Biotech and Pharmaceuticals Medicine

  • Healthy Business - A CNBC Special Report

    The Centers for Disease Control considers obesity in America an epidemic; more than one out of three adults and 17 percent of all children are technically overweight to the point of obesity.

  • weight_training_67x50.jpg

    American spends more on health care than any other country. Do you know where it goes?

  • Biotechs are addicted to capital like "crack addicts are addicted to crack," because of the $1 billion-plus price tag that it takes to bring a drug to market, Gregory Brown, founder and managing director of Cowen Healthcare Royalty Partners, told CNBC Monday.

  • stethoscope_money_200.jpg

    Expensive, aggressive treatments are often superior to other alternatives, but, too often, we confuse expensive and aggressive treatments with effective ones. No treatment path is risk-free, and every treatment carries the risk of flawed execution by the physician or the patient, which creates new and sometimes greater risks.

  • The Cost of Retirement

    Breaking down the anticipated healthcare costs for retirees, with Brad Kimler, Fidelity Investments executive vice president.

  • Bullish on Biotech

    Insight on why now is the right time to invest in biotech stocks, with Dr. Mark Monane, Needham & Co. biotech analyst.

  • online_medical_140.jpg

    To receive Federal stimulus money for the implementation of electronic medical records, hospitals and physicians must satisfy the “meaningful use” criteria as defined by the Department of Health and Human Services. Although Stage 1 criteria appear to be more of a checklist of how to use these systems, subsequent stages will be more complex and difficult to satisfy, thereby putting into jeopardy the continued qualification for these funds by hospitals and physicians.

  • Health Care and RIMM Ahead of Earnings

    It's been one year since President Obama signed the health care bill, and health care stocks have done pretty well. And a look at Research in Motion ahead of tomorrow's earnings announcement, with Colin Gillis, BGC Partners, CNBC's Melissa Lee and the Fast Money traders.

  • Is the iPad The New Stethoscope?

    CNBC's Bertha Coombs interviews Dr. Henry Feldman about using the iPad and how it has changed the way he and his fellow doctors interact with patients at Boston's Beth Israel Deaconess Medical Center.

  • man_botox_200.jpg

    How do you know that 2010 was a good year for Wall Street? That male-dominated world can now afford facelifts to remove worry lines etched in when business dove and bonuses disappeared.

  • Time to Strike?

    Cramer offers up a medical opinion for those who feel their portfolio is under the weather.

  • Kelly Space, Norhtweswtern Univ. graduate, went online to solicit contributions to pay off student loans.

    You can promote yourself online and seek donations or donate parts of your body for hefty fees.

  • retired_couple_beach_200.jpg

    An estimated half a million American seniors have moved overseas to retire, and that number is growing. Some relocate abroad to get a bigger bang for their ever-shrinking retirement buck. Others go in search of adventure.

  • Investors in Emergency Medical Services Corp. are scratching their heads with one hand and calling their lawyers with the other as they try to understand how the company paid $300 million in “transaction costs” for its $3.2 billion leveraged buyout and why those costs were included in the purchase price.

  • alzheimers_brain_scan_200.jpg

    An advisory committee to the Food and Drug Administration recommended unanimously Thursday that the agency approve the first test — a brain scan — that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person.  The New York Times reports.

  • Surgeons

    The Food and Drug Administration will announce new rules for how it intends to license orthopedic players—specifically for hip, knee and and spine products.

  • prescription_pills_200.jpg

    Latin America is a “very underestimated area of opportunity” for business, Chris Viehbacher, CEO of the drugmaker Sanofi-Aventis, told CNBC Tuesday.

  • swine_flu_needle_200.jpg

    Tackling the subject of improving health is complex and to know where we can have the most effect, sparks a lengthy and challenging debate. As the world continues to evolve, science will continue to offer exciting new discoveries. But it will also see the appearance of new diseases, the evolution of existing diseases and the re-emergence of old diseases to continually challenge the state of our health. However, for me, it is chronic disease that is the biggest healthcare challenge facing us, which has been largely unforeseen and is not being addressed adequately.

  • brain_xrays_1_200.jpg

    A growing form of radiation therapy injures patients when its pinpoint beam is allowed to spread too far. The New York Times reports.

  • Kelly Space, Norhtweswtern Univ. graduate, went online to solicit contributions to pay off student loans.

    You can promote yourself online and seek donations or donate parts of your body for hefty fees.